Authors with new study data or developments to report who were unable to submit abstracts by the April 15 deadline are invited to submit abstracts June 3-14.
Late Breaking Abstracts must satisfy one of the two following criteria:
1. Abstract describes a major clinical trial that is likely to have significant impact on clinical practice, using data unavailable by the regular abstract submission deadline of April 15, 2020.
2. Abstract describes a discovery representing a major advance in the field based on critical experiment(s) performed after the regular abstract deadline of April 15, 2020.
PLEASE BEGIN A SUBMISSION ONLY AFTER
1) COMPLETELY READING GUIDELINES AND
2) FINAL ABSTRACT IS READY TO UPLOAD/SUBMIT